Entrectinib can induce nerve cell damage
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
The tyrosine receptor kinase inhibitor (TRKi) entrectinib is used to treat neurotrophic tyrosine receptor kinase (NTRK) fusion-positive solid tumors and ROS1-positive patients.
创建时间：
2025-02-05
